AbbVie to buy Allergan in $63b mega-merger
The deal is the second huge merger this year, after January’s Bristol-Myers Squibb & Celgene deal.
Read More
Tag: Botox
Superdrug to offer stricter mental health checks for Botox users
NHS England’s medical director has welcomed the introduction of stronger mental health safeguards for Superdrug’s new high street botox plan.
Read More
Mylan, Revance link to develop Botox biosimilar
Mylan and Revance Therapeutics have unveiled plans to develop a biosimilar to Allergan’s neuromodulator Botox.
Read More
Allergan to move Botox into PhIII for depression
Allergan has reported mixed top-line data from a mid-stage trial testing Botox as a treatment for major depressive disorder (MDD), but says the results are “encouraging” and warrant a move into Phase III development.
Read More
Six new medicines accepted for NHS use in Scotland
Cost regulators for NHS treatments in Scotland have backed six medicines offering new options to some patients with cancer, chronic migraine, high cholesterol and iron deficiency.
Read More
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
